Search Results - "Backes, F.J."

The mutational spectrum of FOXA2 in endometrioid endometrial cancer points to a tumor suppressor role by Smith, B, Neff, R, Cohn, D.E, Backes, F.J, Suarez, A.A, Mutch, D.G, Rush, C.M, Walker, C.J, Goodfellow, P.J

“…Abstract Background Forkhead box protein A2 (FOXA2) plays an important in development, cellular metabolism and tumorigenesis. The Cancer Genome Atlas (TCGA)…”
Get full text

Outcomes in early-stage cervical cancer patients with high-risk features on conization followed by low-risk features on radical hysterectomy by Smith, B, Backes, F.J, O'Malley, D.M, Cohn, D.E, Fowler, J.M, Copeland, L.J, Salani, R

Get full text

Functional characterization of recurrent FOXA2 mutations in endometrial cancer by Neff, R, Rush, C.M, Walker, C.J, Backes, F.J, Cohn, D.E, Goodfellow, P.J

Get full text

Change in genetics service model increases ovarian cancer patient referrals and decreases time to consultation: Improving compliance with guideline-based quality care by Senter, L, O'Malley, D.M, Backes, F.J, Copeland, L.J, Fowler, J.M, Salani, R, Cohn, D.E

Get full text

Epigenetic regulation of FOXA2 in endometrial cancer by Neff, R, Smith, B, Cohn, D.E, Backes, F.J, Mutch, D.G, Goodfellow, P.J

Get full text

Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated comprehensive cancer center by ElNaggar, A.C, Liang, M.I, O'Malley, D.M, Hade, E.M, Copeland, L.J, Fowler, J.M, Salani, R, Backes, F.J, Cohn, D.E

Get full text

A single institution pilot study for universal Lynch syndrome screening: A key step towards statewide screening and care by Cosgrove, C.M, Backes, F.J, Hampel, H, Salani, R, Copeland, L.J, O'Malley, D.M, Fowler, J.M, Pearlman, R, Cohn, D.E, Goodfellow, P.J

Get full text

Neoadjuvant chemotherapy for the treatment of stage IV endometrial adenocarcinoma: A retrospective cohort by ElNaggar, A.C, Neff, R, Ulm, M, Naeem, U, Fowler, J.M, Cohn, D.E, Backes, F.J, Tillmanns, T

Get full text

Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal cytoreductive surgery by Bixel, K, Vetter, M.H, Cohn, D.E, Fowler, J.M, Copeland, L.J, O'Malley, D.M, Salani, R, Backes, F.J

Get full text

Outcomes of pelvic exenteration: Does size matter? by Smith, B, Jones, E.L, Kitano, M, Lyell, N.J, Backes, F.J, Abdel-Misih, S, Gleisner, A.L, Cheng, G, McCarter, M.D

Get full text

Genome-wide association study (GWAS) of single nucleotide polymorphisms (SNPs) and the risk of platinum and taxane toxicities: An analysis of GOG 172 and 182 by Dockery, L.E, Tritchler, D, Krivak, T.C, Kaufman, K, Lankes, H, Bae-Jump, V.L, Berchuck, A, Backes, F.J, Rose, P.G, Tewari, K.S, Birrer, M.J, Moore, K.N, Bookman, M.A

Get full text

Body mass index (BMI) associations, including mismatch repair protein expression, in 1051 endometrial carcinomas by Perrino, C.M, Stephens, J, Backes, F.J, Goodfellow, P.J, Cohn, D.E, Suarez, A

Get full text

Setting the bar: Compliance with ovarian cancer quality indicators at a National Cancer Institute (NCI)-designated Comprehensive Cancer Center (CCC) by ElNaggar, A.C, Nekkanti, S, O'Malley, D.M, Hade, E.M, Copeland, L.J, Fowler, J.M, Salani, R, Backes, F.J, Cohn, D.E

Get full text

Clinical implications for MSI, MLH1 methylation analysis and IHC in Lynch screening for endometrial cancer patients: An analysis of 940 endometrioid endometrial cancer cases from the GOG 0210 study by Cohn, D.E, Mutch, D.G, Broaddus, R, Ramirez, N, Lankes, H, Ali, S, Backes, F.J, Landrum, L.M, Goodfellow, P.J

Get full text

Outpatient rapid desensitization for gynecologic oncology patients with moderate to severe hypersensitivity reactions to platinums by Li, Q, Cohn, D.E, Rhoades, A.G, Backes, F.J, Copeland, L.J, Fowler, J.M, Salani, R, O'Malley, D.M

Get full text

Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer by Nagel, C.I, Backes, F.J, Hade, E.M, Cohn, D.E, Eisenhauer, E.L, O'Malley, D.M, Fowler, J.M, Copeland, L.J, Salani, R

“…Abstract Introduction Hematologic, gastrointestinal, and neurologic complications are common side effects of the platinum and taxane-based chemotherapy used in…”
Get full text

Risk of complications after robotic hysterectomy for endometrial cancer in obese patients with preoperative comorbidities by Liang, M, McCann, G.A.L, Clements, A, Cohn, D.E, O'Malley, D.M, Fowler, J.M, Salani, R, Backes, F.J

Get full text

Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab? by Richardson, D.L, Backes, F.J, Hurt, J.D, Seamon, L.G, Copeland, L.J, Fowler, J.M, Cohn, D.E, O'Malley, D.M

“…Abstract Background. Increased rates of bowel perforation in patients with recurrent epithelial ovarian cancer (EOC) treated with bevacizumab have been…”
Get full text

The Identification of Exosomal Proteins as Biomarkers for High-grade Serous Ovarian Cancer by Lightfoot, M.D.S., Dorayappan, K.D.P., Backes, F.J., Karuppaiyah, S.

Get full text

Validation of the laparoscopic hysterectomy readmission score among gynecologic oncology patients undergoing robotic-assisted hysterectomy by Lightfoot, M.D.S., Vetter, M.H., Paetow, P., Forsyth, K., Backes, F.J.

Get full text